Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

15 trials with published results (18%)

Research Maturity

52 completed trials (62% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.8%

4 terminated out of 84 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

31%

26 trials in Phase 3/4

Results Transparency

29%

15 of 52 completed with results

Key Signals

15 with results93% success

Data Visualizations

Phase Distribution

60Total
Not Applicable (16)
P 1 (7)
P 2 (11)
P 3 (7)
P 4 (19)

Trial Status

Completed52
Unknown15
Recruiting5
Terminated4
Withdrawn4
Not Yet Recruiting2

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 52 completed trials

Clinical Trials (84)

Showing 20 of 20 trials
NCT04838288Phase 4CompletedPrimary

Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™

NCT04572854Phase 2Completed

Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN

NCT06288152Not ApplicableRecruitingPrimary

Evaluation of Thiosulfate Enhanced Organ Preservation Solution in Kidney Transplantation

NCT07392996Active Not RecruitingPrimary

Does Early Postoperative Fluid Management Affect Functional Delayed Graft Function After Living Donor Kidney Transplantation?

NCT07348874Not Yet Recruiting

Predictive Accuracy of Machine Perfusion for Kidney Transplant Outcomes in Germany

NCT07197164Phase 2Recruiting

Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients

NCT07181096Not ApplicableRecruiting

Frailty Among Renal Transplant Recipients and Relation to Chronic Allograft Dysfunction

NCT05632523CompletedPrimary

Early Pharmacological and Immune Monitoring After Conversion to Belatacept in Renal Transplant Patients

NCT07100925Phase 1Not Yet Recruiting

A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma

NCT07065734Phase 4Recruiting

NEgative prEssure Wound Therapy in Renal Transplant

NCT02711826Phase 1Completed

Treg Therapy in Subclinical Inflammation in Kidney Transplantation

NCT06836544Not ApplicableCompletedPrimary

Efficacy of the ALL YOU NEED is LOVE Healthcare Transition Syllabus Among Pre- and Posttransplant Adolescents in Cali, Colombia

NCT05104242Not ApplicableCompletedPrimary

Kidney Transplant Low-AGE Diet Study

NCT06707272CompletedPrimary

A Study of the Correlation Between Donor UDP-Glc and Transplanted Kidney Function

NCT06025240Recruiting

Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients

NCT04711291Not ApplicableWithdrawn

Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes

NCT03043339TerminatedPrimary

Characterization Of the Intestinal Microbiome Evolution After Kidney Transplant Donation or Receipt

NCT05216172Phase 2Completed

AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce

NCT04874896Not ApplicableUnknownPrimary

Influence of the Intestinal Microbiota on the Clinical Course of Renal Transplantation

NCT03020589Phase 4CompletedPrimary

Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients

Scroll to load more

Research Network

Activity Timeline